Citation Impact
Citing Papers
Current Epidemiology and Growing Resistance of Gram-Negative Pathogens
2012
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
2023 Standout
Health care-associated infections – an overview
2018 Standout
Review on plant antimicrobials: a mechanistic viewpoint
2019 Standout
A Comprehensive Overview of the Antibiotics Approved in the Last Two Decades: Retrospects and Prospects
2023
Target protection as a key antibiotic resistance mechanism
2020
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America
2013
Industrial natural product chemistry for drug discovery and development
2013
Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them
2016
‘Green’ synthesis of metals and their oxide nanoparticles: applications for environmental remediation
2018 Standout
2012 and beyond: potential for the start of a second pre-antibiotic era?
2012
Development of a platform for the discovery and practical synthesis of new tetracycline antibiotics
2016
Treatment of Infections Due to MDR Gram-Negative Bacteria
2019
Antibiotic resistance: a rundown of a global crisis
2018 Standout
Natural product synthesis in the age of scalability
2013
Antibiotic Resistance Mechanisms in Bacteria: Relationships Between Resistance Determinants of Antibiotic Producers, Environmental Bacteria, and Clinical Pathogens
2018
Antibiotics bioremediation: Perspectives on its ecotoxicity and resistance
2019 Standout
Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications
2016
The Science of Antibiotic Discovery
2020 Standout
Mechanism of tetracycline resistance by ribosomal protection protein Tet(O)
2013 StandoutNobel
Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options
2019
Antibiotics in the clinical pipeline in 2013
2013
The Evolving Role of Chemical Synthesis in Antibacterial Drug Discovery
2014
Ribosome-targeting antibiotics and mechanisms of bacterial resistance
2013
Antibiotic resistance in the environment
2021 Standout
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
β-Lactams and β-Lactamase Inhibitors: An Overview
2016 Standout
<p>Antimicrobial Resistance: Implications and Costs</p>
2019 Standout
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Antibacterial drug discovery in the resistance era
2016 StandoutNature
The antimicrobial activity of nanoparticles: present situation and prospects for the future
2017 Standout
Multidrug efflux pumps: structure, function and regulation
2018 Standout
Mechanisms of Antibiotic Resistance
2016 Standout
New antibiotics against bacterial resistance
2019
Contribution of Organofluorine Compounds to Pharmaceuticals
2020 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Antibiotic Resistance in Plant-Pathogenic Bacteria
2018
Carbapenem‐resistant Enterobacteriaceae: biology, epidemiology, and management
2014
Antibiotics and Bacterial Resistance in the 21st Century
2014 Standout
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Natural Products in the “Marketplace”: Interfacing Synthesis and Biology
2019
Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem
2014 Standout
Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates
2018
Natural Products as Platforms To Overcome Antibiotic Resistance
2017
Synthesis and Antibacterial Activity of Pentacyclines: A Novel Class of Tetracycline Analogs
2011
Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance
2019
Structural basis for TetM-mediated tetracycline resistance
2012
Bacterial Antibiotic Resistance: The Most Critical Pathogens
2021 Standout
IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs Meropenem in the Treatment of Complicated Intraabdominal Infections
2018
Natural product and natural product derived drugs in clinical trials
2014 Standout
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Fluorine‐Containing Drugs Approved by the FDA in 2018
2019
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
2015
Healthcare-Associated Infections, Infection Control and the Potential of new Antibiotics in Development in the USA
2015
Synthesis, characterization, and biomedical assessment of novel bisimidazole–coumarin conjugates
2021 Standout
Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design
2018 Nobel
A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery
2019 Standout
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
2017 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Works of Corey Fyfe being referenced
Resistance to Macrolide Antibiotics in Public Health Pathogens
2016
Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic
2012
8-Azatetracyclines: Synthesis and Evaluation of a Novel Class of Tetracycline Antibacterial Agents
2011
Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy
2011
Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A Potent, Broad Spectrum Antibacterial Agent
2011
Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
2013
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents
2015